Stocks and Investing
Stocks and Investing
Tue, May 21, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 20, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Glen Santangelo Maintained (TDOC) at Hold with Decreased Target to $14 on, May 20th, 2024
Glen Santangelo of Jefferies, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $16 to $14 on, May 20th, 2024.
Glen has made no other calls on TDOC in the last 4 months.
There are 15 other peers that have a rating on TDOC. Out of the 15 peers that are also analyzing TDOC, 9 agree with Glen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Allen Lutz of "B of A Securities" Maintained at Hold with Decreased Target to $14 on, Tuesday, May 14th, 2024
- Stephen Baxter of "Wells Fargo" Maintained at Hold with Decreased Target to $15 on, Monday, April 29th, 2024
- Charles Rhyee of "TD Cowen" Maintained at Hold with Decreased Target to $15 on, Friday, April 26th, 2024
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $16 on, Friday, April 26th, 2024
- Ryan MacDonald of "Needham" Reiterated at Hold on, Friday, April 26th, 2024
- Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $17 on, Wednesday, March 6th, 2024
- Michael Cherny of "Leerink Partners" Initiated at Hold and Held Target at $17 on, Monday, February 26th, 2024
- Gil Luria of "DA Davidson" Maintained at Hold with Decreased Target to $18 on, Wednesday, February 21st, 2024
- Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $19 on, Wednesday, February 21st, 2024
These are the ratings of the 6 analyists that currently disagree with Glen
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $20 on, Friday, April 26th, 2024
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $18 on, Friday, April 26th, 2024
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $21 on, Friday, April 26th, 2024
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Friday, April 26th, 2024
- Sarah James of "Cantor Fitzgerald" Initiated at Buy and Held Target at $22 on, Thursday, February 29th, 2024
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
Contributing Sources